Screener
Gyre Therapeutics, Inc. GYRE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s price / sales?
- Gyre Therapeutics, Inc. (GYRE) reported price / sales of 6.2× in Q2 2026.
- How has Gyre Therapeutics, Inc.'s price / sales changed year-over-year?
- Gyre Therapeutics, Inc.'s price / sales decreased by 6.2% year-over-year, from 6.6× to 6.2×.
- What is the long-term trend for Gyre Therapeutics, Inc.'s price / sales?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s price / sales has grown at a -42.7% compound annual growth rate (CAGR), from 17.3× to 5.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Gyre Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude